Argenx Shows Deepening Responses For Vyvgart Across The MG Spectrum

Concept of Myasthenia Gravis written on sticky notes isolated on Wooden Table.
Telitacicept's domestic clinical win expected to accelerate global Phase III program for gMG • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Trial Results

More from R&D